Beacon Pharmaceuticals PLC (DSE: BEACONPHAR)

Beacon Pharmaceuticals Revenue

Beacon Pharmaceuticals had revenue of 2.64B BDT in the quarter ending March 31, 2024, with 22.84% growth. This brings the company's revenue in the last twelve months to 9.89B, up 20.79% year-over-year. In the fiscal year ending June 30, 2023, Beacon Pharmaceuticals had annual revenue of 8.51B with 6.07% growth.

• Revenue (ttm): 9.89B
• Revenue Growth: +20.79%
• P/S Ratio: 3.20
• Revenue / Employee: 2.55M
• Employees: 3,872
• Market Cap: 31.65B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2023	8.51B	487.21M	6.07%
Jun 30, 2022	8.02B	901.58M	12.66%
Jun 30, 2021	7.12B	1.53B	27.37%
Jun 30, 2020	5.59B	943.92M	20.31%
Jun 30, 2019	4.65B	886.08M	23.56%